Close

Pre-Open Stock Movers 08/14: (TFFP) (DDS) (RKT) Higher; (PAYS) (EQ) (IQ) Lower (more...)

Go back to Pre-Open Stock Movers 08/14: (TFFP) (DDS) (RKT) Higher; (PAYS) (EQ) (IQ) Lower (more...)

Precigen Inc. (PGEN) Reports First Patient Dosed in Phase I/II Study of First-in-Class PRGN-2009 AdenoVerse Immunotherapy to Treat HPV-associated Cancers

August 17, 2020 7:31 AM EDT

Precigen, Inc. (NASDAQ: PGEN) today announced that the first patient has been dosed with Precigen's PRGN-2009, a first-in-class, off-the-shelf (OTS) investigational immunotherapy utilizing the AdenoVerse platform designed to activate the immune system to recognize and target HPV+ solid tumors (clinical trial identifier:... More